APA (7th ed.) Citation

Geist, M. J. P., Egerer, G., Burhenne, J., & Mikus, G. (2006). Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype. Antimicrobial agents and chemotherapy, 50(9), . https://doi.org/10.1128/AAC.00551-06

Chicago Style (17th ed.) Citation

Geist, Marcus Julian Peter, Gerlinde Egerer, Jürgen Burhenne, and Gerd Mikus. "Safety of Voriconazole in a Patient with CYP2C9*2/CYP2C9*2 Genotype." Antimicrobial Agents and Chemotherapy 50, no. 9 (2006). https://doi.org/10.1128/AAC.00551-06.

MLA (9th ed.) Citation

Geist, Marcus Julian Peter, et al. "Safety of Voriconazole in a Patient with CYP2C9*2/CYP2C9*2 Genotype." Antimicrobial Agents and Chemotherapy, vol. 50, no. 9, 2006, https://doi.org/10.1128/AAC.00551-06.